US Biopsy Devices Market

ID: MRFR/MED/18046-HCR
100 Pages
Nidhi Mandole
Last Updated: April 06, 2026
US Biopsy Devices Market Research Report: Size, Share, Trend Analysis By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles, Biopsy Forceps, Localization Wires, Others), By Applications (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, Others), By Guidance (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, Others) and By End Users (Hospitals & Clinics, Diagnostic & Imaging Centers, Academic & Research Institutes, Others) - Growth Outlook & Industry Forecast 2025 To 2035
US Biopsy Devices Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.83%
2024 Market Size$ 590.1 Million
2025 Market Size$ 624.5 Million
2035 Market Size$ 1,100 Million
Key Players
Becton Dickinson and Company
Boston Scientific Corporation
Medtronic plc
Hologic
Inc.
Thermo Fisher Scientific Inc.
Trends
  • Technological Advancements
  • Rising Demand for Minimally Invasive Procedures
  • Regulatory Support and Streamlined Approvals
Opportunities
  • Growing Geriatric Population
  • Rising Healthcare Expenditure
  • Increasing Incidence of Cancer
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Product Type (USD Million)
      1. 4.1.1 biopsy guns
      2. 4.1.2 biopsy guidance system
      3. 4.1.3 biopsy needles
      4. 4.1.4 biopsy forceps
      5. 4.1.5 localization wires
      6. 4.1.6 others
    2. 4.2 Healthcare, BY Application (USD Million)
      1. 4.2.1 breast biopsy
      2. 4.2.2 prostate biopsy
      3. 4.2.3 liver biopsy
      4. 4.2.4 lung biopsy
      5. 4.2.5 gynecological biopsy
      6. 4.2.6 others
    3. 4.3 Healthcare, BY Guidance Technique (USD Million)
      1. 4.3.1 ultrasound-guided biopsy
      2. 4.3.2 stereotactic guided biopsy
      3. 4.3.3 MRI-guided biopsy
      4. 4.3.4 CT guided biopsy
      5. 4.3.5 others
    4. 4.4 Healthcare, BY End User (USD Million)
      1. 4.4.1 hospitals & clinics
      2. 4.4.2 diagnostic & imaging centers
      3. 4.4.3 academic & research institutes
      4. 4.4.4 others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Becton Dickinson and Company (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Boston Scientific Corporation (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Medtronic plc (IE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Hologic, Inc. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Thermo Fisher Scientific Inc. (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Abbott Laboratories (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Siemens Healthineers AG (DE)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Fujifilm Holdings Corporation (JP)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Cardinal Health, Inc. (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY PRODUCT TYPE
    3. 6.3 US MARKET ANALYSIS BY APPLICATION
    4. 6.4 US MARKET ANALYSIS BY GUIDANCE TECHNIQUE
    5. 6.5 US MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF HEALTHCARE
    9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
    12. 6.12 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    13. 6.13 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY GUIDANCE TECHNIQUE, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY GUIDANCE TECHNIQUE, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY END USER, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY PRODUCT TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
      3. 7.2.3 BY GUIDANCE TECHNIQUE, 2025-2035 (USD Million)
      4. 7.2.4 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Biopsy Devices Market Segmentation

US Biopsy Devices Market By Product Type (USD Million, 2025-2035)

  • biopsy guns
  • biopsy guidance system
  • biopsy needles
  • biopsy forceps
  • localization wires
  • others

US Biopsy Devices Market By Application (USD Million, 2025-2035)

  • breast biopsy
  • prostate biopsy
  • liver biopsy
  • lung biopsy
  • gynecological biopsy
  • others

US Biopsy Devices Market By Guidance Technique (USD Million, 2025-2035)

  • ultrasound-guided biopsy
  • stereotactic guided biopsy
  • MRI-guided biopsy
  • CT guided biopsy
  • others

US Biopsy Devices Market By End User (USD Million, 2025-2035)

  • hospitals & clinics
  • diagnostic & imaging centers
  • academic & research institutes
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.